We are live on ! Find out more
HPC

HM Payson & Co Portfolio holdings

AUM $7.54B
1-Year Est. Return 31.34%
This Fund
S&P 500
This Quarter Est. Return
+12.66%
1 Year Est. Return
+31.34%
3 Year Est. Return
+94.39%
5 Year Est. Return
+124.39%
10 Year Est. Return
+419.98%
AUM
$4.6B
AUM Growth
+$492M
Cap. Flow
+$29.6M
Cap. Flow %
0.64%
Top 10 Hldgs %
30.7%
Holding
1,209
New
99
Increased
196
Reduced
300
Closed
114

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$32.4M
2
LHX icon
L3Harris
LHX
+$11.9M
3
V icon
Visa
V
+$7.78M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$6.1M
5
JNJ icon
Johnson & Johnson
JNJ
+$5.6M

Sector Composition

Rank Sector Weight
1 Technology 27.6%
2 Healthcare 17.94%
3 Financials 12.59%
4 Consumer Discretionary 10.3%
5 Industrials 9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
101
Bristol-Myers Squibb
BMY
$127B
$5.92M 0.13%
94,876
-1,596
-2% -$93.6K
SUSA icon
102
iShares ESG Optimized MSCI USA ETF
SUSA
$3.98B
$5.71M 0.12%
53,739
+2,654
+5% +$273K
IJR icon
103
iShares Core S&P Small-Cap ETF
IJR
$109B
$5.58M 0.12%
48,751
+490
+1% +$55.8K
FISV
104
Fiserv Inc
FISV
$27.2B
$5.33M 0.12%
51,328
-9,740
-16% -$1.01M
KO icon
105
Coca-Cola
KO
$354B
$5.26M 0.11%
88,858
-4,025
-4% -$224K
WHR icon
106
Whirlpool
WHR
$2.42B
$5.24M 0.11%
22,348
-1,215
-5% -$267K
C icon
107
Citigroup
C
$222B
$5.18M 0.11%
85,791
+5,407
+7% +$360K
NSC icon
108
Norfolk Southern
NSC
$78.8B
$5.12M 0.11%
17,207
PM icon
109
Philip Morris
PM
$301B
$4.99M 0.11%
52,561
+375
+0.7% +$35K
VIG icon
110
Vanguard Dividend Appreciation ETF
VIG
$111B
$4.94M 0.11%
28,773
-819
-3% -$135K
ADBE icon
111
Adobe
ADBE
$89.5B
$4.86M 0.11%
8,571
+605
+8% +$378K
ISRG icon
112
Intuitive Surgical
ISRG
$121B
$4.67M 0.1%
13,010
-3,361
-21% -$1.16M
CWST icon
113
Casella Waste Systems
CWST
$5.69B
$4.66M 0.1%
54,517
EMNT icon
114
PIMCO Enhanced Short Maturity Active ESG ETF
EMNT
$212M
$4.5M 0.1%
44,880
-180
-0.4% -$18.1K
IWM icon
115
iShares Russell 2000 ETF
IWM
$80.9B
$4.46M 0.1%
20,050
+55
+0.3% +$12.4K
TFX icon
116
Teleflex
TFX
$5.85B
$4.33M 0.09%
13,175
-2,990
-18% -$1.02M
FBIN icon
117
Fortune Brands Innovations
FBIN
$6.12B
$4.32M 0.09%
47,287
+12,465
+36% +$1.08M
BSV icon
118
Vanguard Short-Term Bond ETF
BSV
$44.6B
$4.27M 0.09%
52,880
+6,647
+14% +$541K
IGSB icon
119
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
$4.23M 0.09%
78,543
+1
+0% +$54
EMR icon
120
Emerson Electric
EMR
$82.9B
$4.1M 0.09%
44,084
-3,022
-6% -$285K
TRV icon
121
Travelers Companies
TRV
$80.8B
$3.98M 0.09%
25,417
-1,100
-4% -$172K
LMT icon
122
Lockheed Martin
LMT
$134B
$3.86M 0.08%
10,856
-206
-2% -$71.2K
MPC icon
123
Marathon Petroleum
MPC
$90.3B
$3.74M 0.08%
58,437
-6,600
-10% -$424K
UL icon
124
Unilever
UL
$131B
$3.71M 0.08%
61,395
-5,617
-8% -$334K
ENOV icon
125
Enovis
ENOV
$1.56B
$3.69M 0.08%
46,701
+1,148
+3% +$96K

Similar funds

HM Payson & Co's Q4 2021 Portfolio in Review

As of Q4 2021, HM Payson & Co held 1,209 positions worth $4.6B, up 12% from $4.11B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

HM Payson & Co's Q4 2021 filing shows 99 new, 196 increased, 300 reduced and 114 closed positions. Its largest new stake was Peoples Bancorp: 23,400 shares worth $744K. The largest sale was Amgen, an estimated $32.4M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • HM Payson & Co's largest Q4 2021 buy was Peoples Bancorp: 23,400 shares worth $744K.
  • HM Payson & Co added most to CVS Health in Q4 2021, an estimated $49.2M increase.
  • HM Payson & Co's biggest Q4 2021 reduction was Amgen, cutting an estimated $32.4M.
  • HM Payson & Co fully exited Invesco BulletShares 2021 Corporate Bond ETF in Q4 2021, selling an estimated $5.01M.
  • HM Payson & Co's ten largest holdings make up 31% of its $4.6B portfolio in Q4 2021.
  • HM Payson & Co opened 99 new positions and closed 114 in Q4 2021.
  • HM Payson & Co's portfolio value rose 12% quarter-over-quarter to $4.6B.

Based on HM Payson & Co's 13F filing for Q4 2021, filed 15 Feb 2022.